Biopsy Market:  Consumer Trends and Forecast: Shaping Industry Demand to 2030

Comments · 6 Views

Biopsies have advanced significantly, especially in the case of malignancy. Advances in technology have led to improvements in the molecular characterisation of cancers through biopsies. They have been frequently used to determine the stage of the disease, the morphology of the tumor, and

Projection of Revenue Growth:

The Biopsy Market size is expected to grow from US$ 32.38 Bn in 2023 to US$ 67.83 Bn by 2030. The Global Biopsy Market is expected to grow at a CAGR of 11.14% through the forecast period (2024 to 2030).

Biopsy Market Overview:

The comprehensive market analysis explores the dynamic competitive landscape, providing vital insights into market share data and detailed profiles of major global companies. By thoroughly examining the Biopsy Market, the study highlights the key factors influencing regional differences in industry growth.

Details insights on this market, request for methodology here:https://www.maximizemarketresearch.com/request-sample/116684/ 

Biopsy Market Scope: 

After the market valuation phase, extensive primary research was performed to collect, analyze, and verify critical data. This involved evaluating market size, forecasting future trends, identifying key factors, and ensuring data accuracy through triangulation. Utilizing both top-down and bottom-up approaches, along with additional verification methods, we carefully examined market segments and sub-segments. The data collected was subjected to thorough qualitative and quantitative analysis, ensuring that the report offers comprehensive insights.

Biopsy Market Regional Insights

The detailed regional analysis in Biopsy market research identifies key drivers and highlights regulatory changes affecting current and future market trends. By examining both existing and emerging patterns, the research uncovers hidden market potential and identifies lucrative opportunities for enhancing market positioning. This evaluation, which takes into account both present conditions and future developments, provides a comprehensive understanding of the dynamics across different geographic markets.

Biopsy Market Segmentation

by Product

Instruments
Kits and Consumables
Services


by Type

Tissue Biopsies
Liquid Biopsies
Others


by Application

Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Liver Cancers
Pancreatic Cancers
Ovarian Cancers
Others

Biopsy Market Key Players

North America
1. Illumina, Inc.(U.S)
2. Quest Diagnostics (U.S)
3. Abbott Laboratories (U.S)
4. GenMark Diagnostics(U.S)
5. Bio-Rad Laboratories (U.S)
6. Agilent Technologies (U.S)
7. Biomarker Technologies (U.S)
8. Coherent, Inc. (U.S)
9. Cardinal Health (U.S)
10. BD (Becton, Dickinson and Company) (U.S)
11. Myriad Genetics (U.S)
12. Hologic, Inc. (U.S)
13. Biocept, Inc. (U.S)
14. Thermo Fisher Scientific, Inc. (U.S)
15. Danaher (U.S)
16. Guardant Health (U.S)
17. Exact Sciences Corporation (U.S)
18. Freenome Holdings, Inc. (U.S)
19. Biodesix (Integrated Diagnostics) (U.S)
20. HelioHealth (Laboratory for Advanced Medicine) (U.S)
21. Genesystems, Inc. (Genesys Biolabs)(U.S)
22. GRAIL, Inc. (U.S)
Europe
1. ANGLE Plc (U.K)
2. Oncimmune (U.K)
3. Epigenomics AG (Germany)
4. Qiagen N.V. (Netherlands)
5. F. Hoffmann-La Roche Ltd. (Switzerland)
Asia Pacific
1. Sysmex Corporation (Japan)
2. Olympus(Japan)
3. Lucence Diagnostics Pte. Ltd. (Singapore)

Please Contact Us On link:https://www.maximizemarketresearch.com/market-report/global-biopsy-market/116684/ 

Conclusion:
The global biopsy market is set to expand significantly, projected to grow from USD 32.38 billion in 2023 to USD 67.83 billion by 2030, with a robust CAGR of 11.14%. This growth is driven by advancements in molecular testing, the increasing use of liquid biopsies for non-invasive cancer detection, and the integration of AI to enhance diagnostic accuracy. North America leads the market due to its adoption of advanced technologies and focus on early cancer detection, while the Asia Pacific region shows promising growth potential driven by rising cancer awareness and improved healthcare infrastructure. Despite high costs and the presence of synthetic alternatives, the market's innovation and increasing demand for minimally invasive procedures are likely to sustain its upward trajectory.

Explore our top-performing reports on the latest trends:

Global Automation-as-a-Service Market https://www.maximizemarketresearch.com/market-report/automation-service-market/3070/ 
North America Enterprise File Synchronization and Sharing Market https://www.maximizemarketresearch.com/market-report/north-america-enterprise-file-synchronization-and-sharing-market/8037/ 

About Maximize Market Research: 

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Contact Maximize Market Research: 

MAXIMIZE MARKET RESEARCH PVT. LTD.

   ⮝ 3rd Floor, Navale IT park Phase 2,

   Pune Banglore Highway, Narhe

   Pune, Maharashtra 411041, India.

   ✆ +91 9607365656

  ? sales@maximizemarketresearch.com

? www.maximizemarketresearch.com

 

 

 

 

Comments